Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy

NCT01430351 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

144

Enrollment

OTHER

Sponsor class

Stopped \<75 % participant accrual

Conditions

Glioblastoma
Gliosarcoma
Supratentorial Glioblastoma

Interventions

DRUG: Mefloquine
DRUG: Memantine Hydrochloride
DRUG: Metformin Hydrochloride
DRUG: Temozolomide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]